Sonova Holding (OTCMKTS:SONVY) Shares Shorted: Short Interest Down 36.0% in September

Sonova Holding (OTCMKTS:SONVY) was the target of a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling 8,879 shares, a decline of 36.0% from the September 15th total of 13,880 shares. Based on an average daily volume of 27,207 shares, the short-interest ratio is currently 0.3 days. Currently, 0.0% of the shares of the company are short sold.

Sonova Stock Up 2.6%

Shares of Sonova stock opened at $66.33 on Friday. The firm’s 50-day moving average price is $59.25 and its two-hundred day moving average price is $52.74. The company has a current ratio of 1.75, a quick ratio of 1.43 and a debt-to-equity ratio of 0.51. Sonova has a 12-month low of $42.26 and a 12-month high of $66.33.

Wall Street Analysts Forecast Growth

SONVY has been the subject of several recent research reports. The Goldman Sachs Group raised shares of Sonova from a “hold” rating to a “buy” rating in a research report on Thursday, October 8th. Citigroup reaffirmed a “sell” rating on shares of Sonova in a report on Friday, July 24th. UBS Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a research report on Wednesday, July 22nd. Finally, Morgan Stanley upgraded Sonova from an “underweight” rating to an “equal weight” rating in a report on Tuesday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

Sonova Company Profile

Sonova Holding AG is a Switzerland-based hearing-care company that develops, manufactures and distributes solutions for people with hearing loss. Its products and services include hearing aids, cochlear implants, wireless communication systems and related accessories, as well as professional hearing-care services.

The company’s portfolio includes well-known brands such as Phonak, Unitron and Advanced Bionics. Sonova also operates hearing-care retail businesses in several markets, serving customers through audiology clinics, specialist retailers and other distribution channels.

Founded in 1947 and headquartered in Stäfa, Switzerland, Sonova serves customers through operations and sales networks across Europe, North America, Asia-Pacific and other international markets.